Literature DB >> 15918290

Use of influenza antivirals during 2003-2004 and monitoring of neuraminidase inhibitor resistance.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15918290

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  5 in total

1.  Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.

Authors:  Beate Sander; Frederick G Hayden; Marlene Gyldmark; Louis P Garrison
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Resistance to anti-influenza agents.

Authors:  Yi Guan; Honglin Chen
Journal:  Lancet       Date:  2005-09-22       Impact factor: 79.321

3.  Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal.

Authors:  Ndongo Dia; Mbayame N Niang; Saadiya A Diadhiou; Déborah G Goudiaby; Abdourahmane Faye; Davy Kiori; Mady Bâ; Rémy Michel; Ousmane M Diop
Journal:  BMC Infect Dis       Date:  2013-02-27       Impact factor: 3.090

4.  Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Authors:  Adam Meijer; Angie Lackenby; Olav Hungnes; Bruno Lina; Sylvie van-der-Werf; Brunhilde Schweiger; Matthias Opp; John Paget; Jan van-de-Kassteele; Alan Hay; Maria Zambon
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

5.  Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.

Authors:  Jeff Butler; Kathryn A Hooper; Stephen Petrie; Raphael Lee; Sebastian Maurer-Stroh; Lucia Reh; Teagan Guarnaccia; Chantal Baas; Lumin Xue; Sophie Vitesnik; Sook-Kwan Leang; Jodie McVernon; Anne Kelso; Ian G Barr; James M McCaw; Jesse D Bloom; Aeron C Hurt
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.